K-Vitum – indications, contraindications, warnings

K-Vitum is a dietary food for special medical purposes containing vitamin K. The supplement is recommended in the prevention of vitamin K deficiency disease in breastfeeding newborns and infants from 8 days of age to 3 months of age. Vitamin K contained in the product affects the proper blood clotting. The preparation is available in two forms: as drops squeezed from twist-off capsules or as oral drops.

K-Vitum, Producer: Oleofarm

form, dose, packaging availability category the active substance
drops squeezed from twist-off capsules; 25 µg; 2 x 36 pieces food for special medical purposes phytomenadione (also known as phylloquinone, vitamin K1)
S1,2 oral drops; 25 µg / 10 drops; 13 ml

K – Vitum – indications

K-Vitum is a preparation recommended in dietary management:

  1. in the lack of vitamin K,
  2. in the prevention of vitamin K deficiency disease in breastfed newborns and infants from 8 days of age to 3 months of age.

K – Vitum and contraindications

Contraindications to the use of K-Vitum are:

  1. hypersensitivity to any component of the preparation,
  2. should not be used parenterally.

Dosage of the preparation

K-Vitum is in the form of drops squeezed out of capsules. You should twist the tip of the capsule and tear off, and then squeeze the content of 1 capsule into the previously downloaded mother’s milk or directly into the baby’s mouth. When administering the supplement, be especially careful so that the child does not swallow the capsule.

  1. Newborns from 8 days of age and infants up to 3 months of age, breastfed: 25 mg (the content of 1 capsule being opened) once a day.
  2. Preparation in the form of oral drops: 25 µg, ie 10 drops into the expressed mother’s milk or directly into the child’s mouth once a day.

K-Vitum – warnings

  1. You should take K-Vitum under medical supervision.
  2. There is no information on the effect of the supplement on the ability to drive and use machines.
  3. Do not exceed the recommended dose of K-Vitum.

Leave a Reply